from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1494/mazE4

LFCtreatmentdescriptionclass of inhibitor

0.396

Amikacinug/mL Amikacintranslation

1.842

Cap5-10ug/mL Capreomycintranslation

1.945

Rox10-50 ug/mL Roxithromycintranslation

1.064

SM2-5 ug/mL Streptomycintranslation

1.762

Tet5-10 ug/mL Tetracyclinetranslation

-0.029

Rif0.2-5ug/mL Rifampicintranscription

-0.501

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.613

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.535

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.921

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.039

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.735

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.022

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.437

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.139

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.655

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.065

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.022

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.109

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.355

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.842

KCN5-20 ug/mL Potassium cyaniderespiration

0.341

NaN30.2-2 mM Sodium aziderespiration

-0.464

Nigericin50 uM Nigericinrespiration

-0.625

TRC10-150 ug/mL Triclosanrespiration

-0.588

TRZ10-25 ug/mL Thioridazinerespiration

1.427

Valinomycin0.5-10 uM Valinomycinrespiration

0.394

ZnSO42 mM ZnSO4respiration

0.188

menadione6-10 ug/mL Menadionerespiration

0.216

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.107

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.205

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.173

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.066

NRP_1Non-replicating persistence stage 1dosRassociated

0.299

Amp0.2mg/mL AmpicillincellWall

-0.061

Cephalexin20-100 ug/mL CephalexincellWall

0.764

Cerulenin0.32-5 ug/mL CerulenincellWall

0.054

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.097

EMB10-20 ug/mL EthambutolcellWall

0.522

Eta12-40 ug/mL EthionamidecellWall

0.732

INH0.2-0.4 ug/mL IsoniazidcellWall

0.049

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.749

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.202

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.754

BZA0.12 mg/mL BenzamidearomaticAmides

0.342

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.103

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.419

H2O24 mM hydrogen peroxideDNAdamaging

-0.431

Levo10 ug/mL LevofloxacinDNAdamaging

0.581

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.217

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.725

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.056

UVUV-irradiationDNAdamaging

0.918

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.129

Antimycin12.5-50 ug/mL Antimycin A?

-0.257

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.201

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.241

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.990

PA8240.2-2 ug/mL PA-824?

1.258

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.361

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.503

Verapamil50 uM Verapamil?

-0.242

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.320

methoxatin10-20 ug/mL Methoxatin?